SWG Preceptorship Program

The SWG Preceptorship Program provides funding to enable an SWG create its own preceptorship to promote learning and innovation in our community.

The call for proposals is not open yet.

About the SWG Preceptorship Program

The SWG Preceptorship Program is a new EHA initiative. It aims to foster skills, knowledge-sharing, and professional development within the SWG community by empowering an SWG to organize and run its own preceptorship. Participants of this preceptorship will then receive:

  • In-depth, hands-on experience and mentorship from seasoned experts
  • Practical insights and a comprehensive understanding of key concepts and practices in their respective fields

By offering structured training sessions and direct exposure to real-world scenarios, the preceptorship will bridge the gap between theoretical knowledge and practical application. This will empower participants and help them to excel in their roles.

How this initiative will benefit our SWG network

One of the main aims of the SWG Preceptorship Program is to strengthen collaboration and knowledge-sharing within the SWG network.

Through close interaction with experienced preceptors and peers, participants will be able to build valuable connections and foster a culture of continuous learning and innovation.

This initiative enhances individual competency and contributes to the SWG community’s overall growth and excellence—aligning with our mission to promote high standards and best practices across the industry.

Support EHA can provide

EHA can provide financial support for SWG preceptorships. These funds will be used for:

  • Logistics and event organization, AV support, recording of the preceptorship—in the form of in-kind support from EHA
  • Accommodation and travel for the SWG preceptorship faculty
  • The complimentary registration of up to 30 participants, and the reimbursement of their travel and accommodation costs
  • A faculty dinner and welcome reception, etc.

How to apply

The Chair or Vice-Chair of the relevant SWG must complete an online application form to apply for support.

A single SWG can submit multiple proposals.

Guidance for Chairs or Vice-Chairs who are completing the form

When you complete the form, you’ll be asked to provide information on your proposed preceptorship, including the:

  • Topic, learning goals, and objectives
  • Target audience
  • Date and time
  • SWG preceptorship lead (the person who will work with the EHA Office to organize the preceptorship)
  • Country, city, and the name of the hospital/university clinic

You must check your proposed format, target audience, and possible dates to avoid overlaps with similar meetings organized by other societies.

What happens after you apply

Once the deadline has passed, the SWG Committee will assess your application. In particular, it will consider the:

  • Novelty and relevance to current trends in hematology
  • Educational gaps this preceptorship may cover
  • Engagement, scientific, and educational value
  • Sponsor interest

The committee will make its decision and inform successful applicants after the call closes in 2026. If your application is successful, the EHA Executive Office will contact you to discuss the next steps.

If you have questions or need help

Contact the Specialized Working Group Manager at swgs@ehaweb.org.

SWG Pilot Preceptorship 2025

In 2025, the SWG Committee selected a proposal to organize a SWG pilot preceptorship on AML Diagnostics. The event, which took place from October 1-3, 2025, at the Center for Hemato-Oncology Research (CREO) in Perugia, Italy, offered participants an intensive, hands-on overview of AML diagnostics. 26 participants joined an expert panel to dive deep into a comprehensive journey through the diagnostic workflow, beginning with clinical and hematologic assessment, progressing through cytomorphology and flow cytometry, and concluding with cytogenetic and molecular analyses.

Through this integrated approach, participants gained practical experience in interpreting and correlating clinical, morphologic, and molecular data to achieve accurate AML diagnosis, classification, and risk stratification. Read the full meeting report for more details.

 

 

Share